|
1
|
Kitahara CM and Sosa JA: The changing
incidence of thyroid cancer. Nat Rev Endocrinol. 12:646–653. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Qu Y, Zhuo L, Li N, Hu Y, Chen W, Zhou Y,
Wang J, Tao Q, Hu J, Nie X and Zhan S: Prevalence of post-stroke
cognitive impairment in china: A community-based, cross-sectional
study. PLoS One. 10:e01228642015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Smallridge RC, Ain KB, Asa SL, Bible KC,
Brierley JD, Burman KD, Kebebew E, Lee NY, Nikiforov YE, Rosenthal
MS, et al: American Thyroid Association guidelines for management
of patients with anaplastic thyroid cancer. Thyroid. 22:1104–1139.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Giuffrida D and Gharib H: Anaplastic
thyroid carcinoma: Current diagnosis and treatment. Ann Oncol.
11:1083–1089. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rao SN, Zafereo M, Dadu R, Busaidy NL,
Hess K, Cote GJ, Williams MD, William WN, Sandulache V, Gross N, et
al: Patterns of treatment failure in anaplastic thyroid carcinoma.
Thyroid. 27:672–681. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wuebben EL and Rizzino A: The dark side of
SOX2: Cancer-a comprehensive overview. Oncotarget. 8:44917–44943.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sanada Y, Yoshida K, Ohara M, Oeda M,
Konishi K and Tsutani Y: Histopathologic evaluation of stepwise
progression of pancreatic carcinoma with immunohistochemical
analysis of gastric epithelial transcription factor SOX2:
Comparison of expression patterns between invasive components and
cancerous or nonneoplastic intraductal components. Pancreas.
32:164–170. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li XL, Eishi Y, Bai YQ, Sakai H, Akiyama
Y, Tani M, Takizawa T, Koike M and Yuasa Y: Expression of the
SRY-related HMG box protein SOX2 in human gastric carcinoma. Int J
Oncol. 24:257–263. 2004.PubMed/NCBI
|
|
9
|
Sattler HP, Lensch R, Rohde V, Zimmer E,
Meese E, Bonkhoff H, Retz M, Zwergel T, Bex A, Stoeckle M and
Wullich B: Novel amplification unit at chromosome 3q25-q27 in human
prostate cancer. Prostate. 45:207–215. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen Y, Shi L, Zhang L, Li R, Liang J, Yu
W, Sun L, Yang X, Wang Y, Zhang Y and Shang Y: The molecular
mechanism governing the oncogenic potential of SOX2 in breast
cancer. J Biol Chem. 283:17969–17978. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Alonso MM, Diez-Valle R, Manterola L,
Rubio A, Liu D, Cortes-Santiago N, Urquiza L, Jauregi P, Lopez de
Munain A, Sampron N, et al: Genetic and epigenetic modifications of
Sox2 contribute to the invasive phenotype of malignant gliomas.
PLoS One. 6:e267402011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Carina V, Zito G, Pizzolanti G, Richiusa
P, Criscimanna A, Rodolico V, Tomasello L, Pitrone M, Arancio W and
Giordano C: Multiple pluripotent stem cell markers in human
anaplastic thyroid cancer: The putative upstream role of SOX2.
Thyroid. 23:829–837. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dooley TP, Reddy SP, Wilborn TW and Davis
RL: Biomarkers of human cutaneous squamous cell carcinoma from
tissues and cell lines identified by DNA microarrays and qRT-PCR.
Biochem Biophys Res Commun. 306:1026–1036. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
da Silveira Mitteldorf CA, de
Sousa-Canavez JM, Leite KR, Massumoto C and Camara-Lopes LH: FN1,
GALE, MET, and QPCT overexpression in papillary thyroid carcinoma:
Molecular analysis using frozen tissue and routine fine-needle
aspiration biopsy samples. Diagn Cytopathol. 39:556–561. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sponziello M, Rosignolo F, Celano M,
Maggisano V, Pecce V, De Rose RF, Lombardo GE, Durante C, Filetti
S, Damante G, et al: Fibronectin-1 expression is increased in
aggressive thyroid cancer and favors the migration and invasion of
cancer cells. Mol Cell Endocrinol. 431:123–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Han SW and Roman J: Fibronectin induces
cell proliferation and inhibits apoptosis in human bronchial
epithelial cells: Pro-oncogenic effects mediated by PI3-kinase and
NF-kappaB. Oncogene. 25:4341–4349. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lou X, Han X, Jin C, Tian W, Yu W, Ding D,
Cheng L, Huang B, Jiang H and Lin B: SOX2 targets fibronectin 1 to
promote cell migration and invasion in ovarian cancer: New
molecular leads for therapeutic intervention. OMICS. 17:510–518.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak JK and Schmittgen TD: Analysis of
relative gene expression data using quantitative PCR and the
2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
He WP, Zhou J, Cai MY, Xiao XS, Liao YJ,
Kung HF, Guan XY, Xie D and Yang GF: CHD1L Protein is overexpressed
in human ovarian carcinomas and is a novel predictive biomarker for
patients survival. BMC Cancer. 12:4372012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Repesh LA: A new in vitro assay for
quantitating tumor cell invasion. Invasion Metastasis. 9:192–208.
1989.PubMed/NCBI
|
|
21
|
Wen Y, Hou Y, Huang Z, Cai J and Wang Z:
SOX2 is required to maintain cancer stem cells in ovarian cancer.
Cancer Sci. 108:719–731. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Basu-Roy U, Bayin NS, Rattanakorn K, Han
E, Placantonakis DG, Mansukhani A and Basilico C: Sox2 antagonizes
the Hippo pathway to maintain stemness in cancer cells. Nat Commun.
6:64112015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kar S, Sengupta D, Deb M, Pradhan N and
Patra SK: SOX2 function and Hedgehog signaling pathway are
co-conspirators in promoting androgen independent prostate cancer.
Biochim Biophys Acta Mol Basis Dis. 1863:253–265. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zheng J, Xu L, Pan Y, Yu S, Wang H,
Kennedy D and Zhang Y: Sox2 modulates motility and enhances
progression of colorectal cancer via the Rho-ROCK signaling
pathway. Oncotarget. 8:98635–98645. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang SX, Polley E and Lipkowitz S: New
insights on PI3K/AKT pathway alterations and clinical outcomes in
breast cancer. Cancer Treat Rev. 45:87–96. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yue S, Li J, Lee SY, Lee HJ, Shao T, Song
B, Cheng L, Masterson TA, Liu X, Ratliff TL and Cheng JX:
Cholesteryl ester accumulation induced by PTEN loss and PI3K/AKT
activation underlies human prostate cancer aggressiveness. Cell
Metab. 19:393–406. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chang F, Lee JT, Navolanic PM, Steelman
LS, Shelton JG, Blalock WL, Franklin RA and McCubrey JA:
Involvement of PI3K/Akt pathway in cell cycle progression,
apoptosis, and neoplastic transformation: A target for cancer
chemotherapy. Leukemia. 17:590–603. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Weina K and Utikal J: SOX2 and cancer:
Current research and its implications in the clinic. Clin Transl
Med. 3:192014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gut A, Moch H and Choschzick M: SOX2 gene
amplification and overexpression is linked to HPV-positive vulvar
carcinomas. Int J Gynecol Pathol. 37:68–73. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Qian P, Zuo Z, Wu Z, Meng X, Li G, Wu Z,
Zhang W, Tan S, Pandey V, Yao Y, et al: Pivotal role of reduced
let-7g expression in breast cancer invasion and metastasis. Cancer
Res. 71:6463–6474. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liao YX, Zhang ZP, Zhao J and Liu JP:
Effects of fibronectin 1 on cell proliferation, senescence and
apoptosis of human glioma cells through the PI3K/AKT signaling
pathway. Cell Physiol Biochem. 48:1382–1396. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rinkenbaugh AL and Baldwin AS: The NF-κB
pathway and cancer stem cells. Cells. 5:E162016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang J, Deng L, Huang J, Cai R, Zhu X, Liu
F, Wang Q, Zhang J and Zheng Y: High expression of Fibronectin 1
suppresses apoptosis through the NF-κB pathway and is associated
with migration in nasopharyngeal carcinoma. Am J Transl Res.
9:4502–4511. 2017.PubMed/NCBI
|
